Diagnosis of oncological diseases
The EMC Institute of Oncology has all modern facilities for conducting diagnostic studies in order to:
-
detection of malignant tumors at an early stage,
-
determination of the stage of spread of malignant tumors,
-
evaluation of the effectiveness of the treatment.
Each stage is extremely important for treatment planning and plays a key role in the course of treatment.
The EMC Institute of Oncology conducts the full range of modern diagnostic studies, including radiation diagnostics (ultrasound, CT, MRI), radionuclide diagnostics (PET, SPECT), endoscopic and laboratory diagnostics (clinical, genetic and histological studies).
Early diagnosis (screening)
The capabilities of modern medicine make it possible to successfully treat oncological diseases detected at an early stage of their development. In more than 95% of cases, cancer detected at an early stage is curable.
According to international protocols, the EMC Institute of Oncology has developed cancer screening programs, as well as comprehensive cancer diagnostic programs (Onco check-up), which can detect not only malignant neoplasms at an early stage of their development, but also precancerous diseases.
Effective diagnostics in a short time
The EMC Institute of Oncology can perform a full range of diagnostic tests in 1 day: CT, MRI, PET-CT, biopsies under the control of ultrasound, CT, MRI. The diagnosis is carried out according to international protocols by highly qualified specialists with experience in the USA and Western Europe.
The EMC has its own histological laboratory, equipped with the most modern equipment. Laboratory specialists, leading pathomorphologists, histologists from Russia and France, have the latest methods of analyzing the obtained material. The verification of the histological diagnosis is carried out in leading clinics in Europe, Israel and the USA.
Cancer stage diagnosis or treatment response control
With the advent of PET diagnostics, a new era has begun in terms of the accuracy of establishing a malignant diagnosis and monitoring the course of the disease and the course of treatment. Despite the fact that diagnostic methods such as CT and MRI are quite informative, they allow us to judge changes in the size of the tumor to a greater extent. A clear assessment of metabolism, that is, the metabolism of education, and its response to treatment is possible only with PET.
The EMC Institute of Oncology Radionuclide Diagnostics Center conducts a wide range of research PET-CT and SPECT-CT. PET-CT is an indispensable method in oncology that allows assessing the prevalence of the disease, the presence of metastases, and monitoring the effectiveness of treatment. A wide range of SPECT-CT studies include scintigraphy of the sentinel lymph node (the first in the path of lymph outflow) in breast cancer, skin melanoma, and some other diseases. The research is carried out according to European protocols using high-quality radiopharmaceuticals produced in our own laboratory and passed quality control in accordance with international standards.
.webp)
